Literature DB >> 17295614

Voxel-based T2 relaxation rate measurements in temporal lobe epilepsy (TLE) with and without mesial temporal sclerosis.

Susanne G Mueller1, Kenneth D Laxer, Norbert Schuff, Michael W Weiner.   

Abstract

INTRODUCTION: Quantitative measurements of T(2) relaxation in the hippocampus for focus lateralization in mesial temporal lobe epilepsy (mTLE) are well established. Less is known to what degree such relaxation abnormalities also affect regions beyond the ipsilateral hippocampus. Therefore, the aim of this study was to characterize extent and distribution pattern of extrahippocampal relaxation abnormalities in TLE with (TLE-MTS) and without MRI evidence of mesial-temporal sclerosis (TLE-no).
METHODS: Double spin echo images (TE1/2: 20/80 ms) acquired in 24 TLE-MTS and 18 TLE-no were used to calculate relaxation rate maps. These maps were analyzed by SPM2 and by selecting regions of interest (ROI) in the hippocampus and several extrahippocampal brain regions.
RESULTS: In TLE-MTS, the results of the SPM and ROI analysis were in good agreement and showed the most severe relaxation rate decreases in the ipsilateral hippocampus but also in other ipsilateral temporal regions, orbitofrontal, and parietal regions and to a lesser degree in contralateral frontal regions. The relaxation rate decreases in TLE-no were confined to small regions in the ipsilateral anterior inferior and medial temporal lobe in the SPM analysis while ROI analysis showed additional regions in the ipsilateral hippocampus, amygdala, and anterior cingulate.
CONCLUSION: TLE-MTS showed extensive, widespread but predominantly ipsilateral temporal and also extratemporal T(2) relaxation rate decreases. In contrast, the findings of the SPM and ROI analyses in TLE-no suggested that if relaxation rate decreases are present, they are less uniform and generally milder than in TLE-MTS. This further supports the hypothesis that TLE-no is a distinct clinicopathological entity from TLE-MTS and probably heterogeneous in itself.

Entities:  

Mesh:

Year:  2007        PMID: 17295614      PMCID: PMC2744642          DOI: 10.1111/j.1528-1167.2006.00916.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  31 in total

1.  Time-efficient T2 relaxometry of the entire hippocampus is feasible in temporal lobe epilepsy.

Authors:  J von Oertzen; H Urbach; I Blümcke; M Reuber; F Träber; T Peveling; C Menzel; C E Elger
Journal:  Neurology       Date:  2002-01-22       Impact factor: 9.910

2.  Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains.

Authors:  C D Good; I Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-09       Impact factor: 6.556

3.  Widespread microdysgenesis in therapy-resistant epilepsy--a case report on post-mortem findings.

Authors:  S H Eriksson; B Rydenhag; P Uvebrant; K Malmgren; C Nordborg
Journal:  Acta Neuropathol       Date:  2002-01       Impact factor: 17.088

4.  Hippocampal pathology in refractory temporal lobe epilepsy: T2-weighted signal change reflects dentate gliosis.

Authors:  Regula S Briellmann; Renate M Kalnins; Samuel F Berkovic; Graeme D Jackson
Journal:  Neurology       Date:  2002-01-22       Impact factor: 9.910

5.  Measurement of temporal lobe T2 relaxation times using a routine diagnostic MR imaging protocol in epilepsy.

Authors:  M Okujava; R Schulz; A Ebner; F G Woermann
Journal:  Epilepsy Res       Date:  2002-01       Impact factor: 3.045

6.  [18F]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage.

Authors:  S Lamusuo; L Jutila; A Ylinen; R Kälviäinen; E Mervaala; M Haaparanta; S Jääskeläinen; K Partanen; M Vapalahti; J Rinne
Journal:  Arch Neurol       Date:  2001-06

7.  A voxel-based morphometric study of ageing in 465 normal adult human brains.

Authors:  C D Good; I S Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

8.  T2 relaxometry can lateralize mesial temporal lobe epilepsy in patients with normal MRI.

Authors:  A Bernasconi; N Bernasconi; Z Caramanos; D C Reutens; F Andermann; F Dubeau; D Tampieri; B G Pike; D L Arnold
Journal:  Neuroimage       Date:  2000-12       Impact factor: 6.556

9.  Statistical parametric mapping of regional glucose metabolism in mesial temporal lobe epilepsy.

Authors:  P Van Bogaert; N Massager; P Tugendhaft; D Wikler; P Damhaut; M Levivier; J Brotchi; S Goldman
Journal:  Neuroimage       Date:  2000-08       Impact factor: 6.556

10.  Microdysgenesis in temporal lobe epilepsy. A quantitative and immunohistochemical study of white matter neurones.

Authors:  M Thom; S Sisodiya; W Harkness; F Scaravilli
Journal:  Brain       Date:  2001-11       Impact factor: 13.501

View more
  23 in total

1.  Upregulation of inward rectifier K+ (Kir2) channels in dentate gyrus granule cells in temporal lobe epilepsy.

Authors:  Christina C Young; Michael Stegen; René Bernard; Martin Müller; Josef Bischofberger; Rüdiger W Veh; Carola A Haas; Jakob Wolfart
Journal:  J Physiol       Date:  2009-06-29       Impact factor: 5.182

2.  Network Analysis on Predicting Mean Diffusivity Change at Group Level in Temporal Lobe Epilepsy.

Authors:  Farras Abdelnour; Ashish Raj; Orrin Devinsky; Thomas Thesen
Journal:  Brain Connect       Date:  2016-09-07

3.  Temporal lobe regions essential for preserved picture naming after left temporal epilepsy surgery.

Authors:  Jeffrey R Binder; Jia-Qing Tong; Sara B Pillay; Lisa L Conant; Colin J Humphries; Manoj Raghavan; Wade M Mueller; Robyn M Busch; Linda Allen; William L Gross; Christopher T Anderson; Chad E Carlson; Mark J Lowe; John T Langfitt; Madalina E Tivarus; Daniel L Drane; David W Loring; Monica Jacobs; Victoria L Morgan; Jane B Allendorfer; Jerzy P Szaflarski; Leonardo Bonilha; Susan Bookheimer; Thomas Grabowski; Jennifer Vannest; Sara J Swanson
Journal:  Epilepsia       Date:  2020-08-11       Impact factor: 5.864

4.  Quantitative analysis of structural neuroimaging of mesial temporal lobe epilepsy.

Authors:  Negar Memarian; Paul M Thompson; Jerome Engel; Richard J Staba
Journal:  Imaging Med       Date:  2013-06-01

5.  Impact of methodologic choice for automatic detection of different aspects of brain atrophy by using temporal lobe epilepsy as a model.

Authors:  C Scanlon; S G Mueller; D Tosun; I Cheong; P Garcia; J Barakos; M W Weiner; K D Laxer
Journal:  AJNR Am J Neuroradiol       Date:  2011-08-18       Impact factor: 3.825

6.  Network-level analysis of cortical thickness of the epileptic brain.

Authors:  A Raj; S G Mueller; K Young; K D Laxer; M Weiner
Journal:  Neuroimage       Date:  2010-05-27       Impact factor: 6.556

7.  Involvement of the thalamocortical network in TLE with and without mesiotemporal sclerosis.

Authors:  Susanne G Mueller; Kenneth D Laxer; Jerome Barakos; Ian Cheong; Daniel Finlay; Paul Garcia; Valerie Cardenas-Nicolson; Michael W Weiner
Journal:  Epilepsia       Date:  2009-12-01       Impact factor: 5.864

8.  A two-level multimodality imaging Bayesian network approach for classification of partial epilepsy: preliminary data.

Authors:  Susanne G Mueller; Karl Young; Miriam Hartig; Jerome Barakos; Paul Garcia; Kenneth D Laxer
Journal:  Neuroimage       Date:  2013-01-24       Impact factor: 6.556

Review 9.  Affective brain areas and sleep-disordered breathing.

Authors:  Ronald M Harper; Rajesh Kumar; Paul M Macey; Mary A Woo; Jennifer A Ogren
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

10.  Individual feature maps: a patient-specific analysis tool with applications in temporal lobe epilepsy.

Authors:  Diego Cantor-Rivera; John S H Baxter; Sandrine de Ribaupierrre; Jonathan C Lau; Seyed M Mirsattari; Maged Goubran; Jorge G Burneo; David A Steven; Terry M Peters; Ali R Khan
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-11-14       Impact factor: 2.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.